By Business/Source
No Data
By Country/Region
No Data
US Stock MarketDetailed Quotes
Relmada Therapeutics (RLMD)
- 7.640
- +0.120+1.60%
Close May 1 16:00 ET
- 7.150
- -0.490-6.41%
Post 20:01 ET
801.35MMarket Cap-5.27P/E (TTM)
7.805High7.420Low944.17KVolume7.560Open7.520Prev Close7.20MTurnover1.05%Turnover RatioLossP/E (Static)104.89MShares7.94052wk High9.26P/B689.62MFloat Cap0.32352wk Low--Dividend TTM90.26MShs Float54.000Historical High--Div Yield TTM5.12%Range %0.240Historical Low7.626Avg Price1Lot Size
Relmada Therapeutics (RLMD) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm